Edesa Biotech, Inc. (EDSA)
2.02
+0.06
(+3.06%)
USD |
NASDAQ |
Nov 18, 14:44
Edesa Biotech Price : 2.02 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 1.86 | 2.05 | 1.85 | 1.96 | 326770.0 |
| Nov 16, 2026 | 1.94 | 2.00 | 1.735 | 1.89 | 473280.0 |
| Nov 13, 2026 | 1.96 | 2.02 | 1.76 | 1.94 | 510770.0 |
| Nov 12, 2026 | 2.115 | 2.349 | 1.99 | 2.08 | 520660.0 |
| Nov 11, 2026 | 2.11 | 2.32 | 1.85 | 2.22 | 1.018M |
| Nov 10, 2026 | 2.34 | 2.34 | 1.85 | 2.02 | 2.121M |
| Nov 09, 2026 | 3.46 | 3.93 | 2.37 | 2.49 | 84.58M |
| Nov 06, 2026 | 2.12 | 2.20 | 2.01 | 2.14 | 37766.00 |
| Nov 05, 2026 | 2.14 | 2.179 | 2.08 | 2.13 | 33893.00 |
| Nov 04, 2026 | 2.38 | 2.38 | 2.15 | 2.17 | 43999.00 |
| Nov 03, 2026 | 2.49 | 2.49 | 2.244 | 2.28 | 53260.00 |
| Nov 02, 2026 | 2.57 | 2.61 | 2.40 | 2.44 | 44812.00 |
| Oct 30, 2026 | 2.86 | 2.86 | 2.55 | 2.57 | 30635.00 |
| Oct 29, 2026 | 2.55 | 2.820 | 2.55 | 2.70 | 44349.00 |
| Oct 28, 2026 | 2.64 | 2.64 | 2.455 | 2.56 | 70685.00 |
| Oct 27, 2026 | 2.62 | 2.73 | 2.57 | 2.63 | 25869.00 |
| Oct 26, 2026 | 2.70 | 2.74 | 2.54 | 2.59 | 63894.00 |
| Oct 23, 2026 | 2.71 | 2.918 | 2.67 | 2.77 | 18558.00 |
| Oct 22, 2026 | 2.89 | 2.99 | 2.749 | 2.76 | 22690.00 |
| Oct 21, 2026 | 2.87 | 2.93 | 2.70 | 2.85 | 39305.00 |
| Oct 20, 2026 | 2.81 | 3.025 | 2.81 | 2.82 | 35515.00 |
| Oct 19, 2026 | 2.57 | 2.918 | 2.57 | 2.78 | 25040.00 |
| Oct 16, 2026 | 2.68 | 2.766 | 2.52 | 2.57 | 64032.00 |
| Oct 15, 2026 | 2.62 | 2.79 | 2.541 | 2.67 | 75822.00 |
| Oct 14, 2026 | 2.84 | 2.84 | 2.62 | 2.65 | 72593.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ProMIS Neurosciences, Inc. | 3.14 |
| Oncolytics Biotech, Inc. | 0.3898 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 14.64 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| PEG Ratio | -0.0437 |
| Price to Book Value | 48.77 |
| Earnings Yield | -83.75% |
| Market Cap | 19.46M |
| PEGY Ratio | -0.0437 |